Researchers from Karolinska Institutet have discovered how a common Parkinson’s disease treatment, levodopa, can lead to serious psychiatric issues...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - KNOWRIDGE.COM - A La Une - 20/Aug 10:13
This drug improves sleep quality in Parkinson’s disease patients
A recent study involving 22 patients with Parkinson’s disease (PD) has provided new insights into how the dopaminergic drug levodopa affects sleep quality. The study found that when patients took levodopa, their sleep improved significantly. Specifically, the number of times they woke up during the night decreased by 25%, and the total time they remained […]
Articles similaires
Smart brain pacemakers could revolutionize Parkinson’s disease treatment
knowridge.com - 03/Sep 15:04
Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...
Smart brain pacemakers could revolutionize Parkinson’s disease treatment
knowridge.com - 03/Sep 15:04
Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...
These commonly used drugs are linked to Parkinson’s Disease
knowridge.com - 07/Sep 10:30
Parkinson’s disease is a serious condition that affects how the brain controls movement. People with this disease may experience uncontrollable...
These mental health drugs may increase risk of Parkinson’s disease
knowridge.com - 01/Sep 10:13
Parkinson’s disease is a challenging and progressive neurological disorder that affects the brain, leading to symptoms such as uncontrollable...
Ulcers and GI damage linked to higher risk of Parkinson’s disease
knowridge.com - 08/Sep 00:33
A new study from Beth Israel Deaconess Medical Center (BIDMC) has found that people with a history of damage to the lining of their upper...
Ulcers and GI damage linked to higher risk of Parkinson’s disease
knowridge.com - 08/Sep 00:33
A new study from Beth Israel Deaconess Medical Center (BIDMC) has found that people with a history of damage to the lining of their upper...
Could Sulthiame, a Pill Approved in Europe for Epilepsy, Help Ease Sleep Apnea?
drugs.com - 10/Sep 12:09
TUESDAY, Sept. 10, 2024 -- A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame...
Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma
mountaintoday.in - 08:52
Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...
Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma
mountaintoday.in - 08:52
Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...
Les derniers communiqués
-
Aucun élément